JG
TNGX icon

Jain Global’s Tango Therapeutics TNGX Stock Holding History

Jain Global’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$426K Buy
+20,370
New +$284K ﹤0.01% 962
2025
Q2 		– Sell
-30,303
Closed -$41.5K – 1612
2025
Q1 		$41.5K Sell
30,303
-19,489
-39% -$47.9K ﹤0.01% 1017
2024
Q4 		$154K Buy
+49,792
New +$231K ﹤0.01% 666

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Jain Global's TNGX Position: Q1 2026 in Review

Jain Global opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 20,370 shares worth $426K. The stake represents ﹤0.01% of the portfolio and ranks #962 among its holdings. This is a return to the name: Jain Global previously reported a position in TNGX as recently as Q1 2025.

Jain Global first reported a position in TNGX in Q4 2024 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Jain Global held 20,370 shares of Tango Therapeutics worth $426K as of Q1 2026.
  • Tango Therapeutics was a new Jain Global position in Q1 2026.
  • Tango Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q1 2026, its #962 holding.
  • Jain Global first reported a position in Tango Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.